EyeYon Medical’s EndoArt Heads to U.S. Clinical Trial After FDA IDE Approval
A synthetic sliver that could upend corneal edema care in the U.S.—no donor required. EndoArt (EyeYon Medical; Ness Ziona, Israel)…
Riding the Ophthalmology Roller Coaster: AAO 2025, Day 2 Highlights
Hold on tight! Day 2 delivered genetics, glaucoma debates, retina tech and more at AAO 2025. This weekend, Orlando isn’t…
latest posts
